Release Date: 22/08/22 08:43 Summary: Nearmap Board unanimously recommends Thoma Bravo's offer Price Sensitive: Yes Download Document 978.28KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market